Cargando…
Value of anti-infective chemoprophylaxis in primary systemic vasculitis: what is the evidence?
Although infections are a major concern in patients with primary systemic vasculitis, actual knowledge about risk factors and evidence concerning the use of anti-infective prophylaxis from clinical trials are scarce. The use of high dose glucocorticoids and cyclophosphamide pose a definite risk for...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2787252/ https://www.ncbi.nlm.nih.gov/pubmed/19886977 http://dx.doi.org/10.1186/ar2826 |